8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands

Bioorganic & Medicinal Chemistry
2009.0

Abstract

Importance of making available selective adenosine receptor antagonists is boosted by recent findings of adenosine involvement in many CNS dysfunctions. In the present work a series of 8-bromo-9-alkyl adenines are prepared and fully characterized in radioligand binding assays or functional cyclase experiments in respect to their interaction with all the four adenosine receptor subtypes. Results show that the presence of the bromine atom in 8-position of 9-substituted adenines promotes in general the interaction with the adenosine receptors, in particular at the A(2A) subtype. The present study also demonstrates that adenine derivatives could be a good starting point to obtain selective adenosine A(2B) receptor antagonists.

Knowledge Graph

Similar Paper

8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands
Bioorganic & Medicinal Chemistry 2009.0
Structure−Activity Relationships of Adenine and Deazaadenine Derivatives as Ligands for Adenine Receptors, a New Purinergic Receptor Family
Journal of Medicinal Chemistry 2009.0
(E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists
Journal of Medicinal Chemistry 1992.0
Synthesis and Biological Activity of New Potential Agonists for the Human Adenosine A<sub>2A</sub> Receptor
Journal of Medicinal Chemistry 2004.0
Structure−Activity Relationships at Human and Rat A<sub>2B</sub> Adenosine Receptors of Xanthine Derivatives Substituted at the 1-, 3-, 7-, and 8-Positions
Journal of Medicinal Chemistry 2002.0
1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A<sub>2B</sub>Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity
Journal of Medicinal Chemistry 2009.0
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity
Journal of Medicinal Chemistry 2016.0
Xanthine functionalized congeners as potent ligands at A2-adenosine receptors
Journal of Medicinal Chemistry 1987.0
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors
Journal of Medicinal Chemistry 1991.0
Adenosine receptor antagonists: Recent advances and therapeutic perspective
European Journal of Medicinal Chemistry 2022.0